Schedule 13G ownership disclosure
TRACON PHARMACEUTICALS INC
Security class unavailable · CUSIP: 89237H209
Event date: 2022-04-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,466,118
- Percent of class
- 7.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001096906-22-000993
- Form type
- SC 13G
- Filer
- Tracon Pharmaceuticals, Inc.
- CIK
- CIK 1394319
- Filed
- Apr 29, 2022
- Reporting period
- Apr 12, 2022
- Description
- Schedule 13G beneficial ownership